The glutamate antagonist MK‐801 reduces focal ischemic brain damage in the rat

Annals of Neurology

Volumn 24, Issue 4, 1988, Pages 543-551

  Park, C K ^a   Nehls, D G ^a   Graham, D I ^a   Teasdale, G M ^a   McCulloch, J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIZOCILPINE; GLUTAMIC ACID ANTAGONIST;

ANIMAL EXPERIMENT; BRAIN ISCHEMIA; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MAMMAL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; BLOOD PRESSURE; DIBENZOCYCLOHEPTENES; DIZOCILPINE MALEATE; ISCHEMIC ATTACK, TRANSIENT; MALE; RATS; RATS, INBRED STRAINS; RECEPTORS, GLUTAMATE; RECEPTORS, NEUROTRANSMITTER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0023788688     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410240411     Document Type: Article

References (39)

1. Barbiturate protection in focal cerebral ischemia
2. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurological examination
3. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis
4. Focal cerebral ischemia: reduction in size of infarcts by ventriculo‐subarachnoid perfusion with fluorocarbon emulsion
5. Effects of anoxia on the stimulated release of amino acid neurotransmitters in the cerebellum in vitro
6. Hypoxia and vascular disorders of the central nervous system
7. The nature, distribution and earliest stages of anoxic‐ischaemic nerve cell damage in the rat brain as defined by the optical microscope
8. The importance of avoiding “dark” neurones in experimental neuropathology
9. Central sympathomimetic activity of (+)‐5‐methyl‐10, ll‐dihydro‐5H‐dibenzo[a, d]cyclohepten‐5,10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties
10. Cellular origin of ischemia‐induced glutamate release from brain tissue in vivo and in vitro
11. A glutamate antagonist reduces infarction size following focal cerebral ischaemia independently of vascular and metabolic changes
12. Effects of systemic administration of the NMDA antagonist, CPP, on ischemic brain damage in gerbils
13. Kynurenate inhibition of cell excitation decreases stroke size and deficits
14. Systemic administration of MK‐801 protects against ischaemic neuropathology in rats
15. Systemic administration of MK‐801 protects against ischemia‐induced hippocampal neurodegeneration in the gerbil
16. Nimodipine and the haemodynamic and histopathological consequences of middle cerebral artery occlusion in the rat
17. Extracellular overflow of glutamate, aspartate GABA and taurine in the cortex and basal ganglia of fetal lambs during hypoxia‐ischemia
18. Ischemia‐induced shift of inhibitory and excitatory amino acids from intra‐ to extracellular compartments
19. Disposition and metabolism of (+)‐5‐methyl‐10, ll‐dihydro‐5H‐dibenzo[a, d]cyclohepten‐5,10‐imine in rats, dogs and monkeys
20. Non competitive antagonists of excitatory amino acid receptors
21. NMDA‐receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones
22. Adrenergic blockers as cerebral antiischaemic agents
23. Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters
24. Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion
25. The effects of N‐methyl‐D‐aspartate (NMDA) receptor blockade upon local cerebral glucose utilisation and local cerebral blood flow
26. Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia
27. Protective effect of the glutamate antagonist MK‐801 in focal cerebral ischaemia in the cat
28. Selective post‐ischaemic vulnerability in the brain: thrombolytic engendered hemorrhage and synaptic‐induced striatal hippocampal degeneration
29. Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death
30. Glutamate and the pathophysiology of hypoxic‐ischemic brain damage
31. Excitotoxicity and the NMDA receptor
32. Pure cortical ischemia versus striatal ischemia
33. 3H]glutamate uptake into synaptosomes
34. Blockade of N‐methyl‐D‐aspartate receptors may protect against ischemic damage in the brain
35. Cerebral protection with barbiturates: relation to anesthetic effect
36. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion
37. Agonists and antagonists for excitatory amino acid receptors
38. The anticonvulsant MK‐801 is a potent N‐methyl‐D‐aspartate antagonist